Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Date of authorisation: 18/09/2026, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 September 2026 - 11:48

Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Date of authorisation: 18/09/2026, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/susvimo

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters